Recker Matthew J, Rajah Gary B, Tso Michael K, Dossani Rimal H, Levy Elad I
Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York.
Department of Neurosurgery, Gates Vascular Institute at Kaleida Health, Buffalo, New York.
Oper Neurosurg. 2020 Sep 15;19(4):E424-E425. doi: 10.1093/ons/opaa098.
Wide-necked cerebral aneurysms often require complex treatment strategies for optimal treatment. As the surgeon's arsenal continues to expand, consideration of all potential applications of available devices is important. The Woven EndoBridge (WEB) device (MicroVention-Terumo, Aliso Viejo, California) capitalizes on flow disruption to promote thrombosis and is Food and Drug Administration (FDA) approved for saccular wide-necked bifurcation aneurysms located at the middle cerebral artery bifurcation, internal carotid artery (ICA) terminus, anterior communicating artery complex, and basilar apex. In this video, we demonstrate an off-label use of the WEB to treat a wide-necked type II1 ophthalmic artery aneurysm, highlighting the importance of correct device sizing. The patient is a 74-yr-old woman with a family history of aneurysms. Her aneurysm was found incidentally after a minor trauma. Observation and various treatment options were considered. The patient preferred to avoid open surgical intervention and dual antiplatelet therapy. Endoluminal flow diversion for types II and III ophthalmic artery aneurysms has relatively low occlusion rates and a higher incidence of visual field deficits.1 A WEB device can be an excellent alternative to treat these aneurysms. A biaxial system was used to selectively catheterize the supraclinoid internal carotid artery and then the aneurysm, and optimal flow diversion was achieved. The patient did well and was discharged home the next day on aspirin alone. Six-month angiography showed near-occlusion of the aneurysm and ophthalmic artery patency. The neck remnant will be followed up with repeat angiography in 6 mo. The patient gave informed consent for the procedure and video recording. Institutional review board approval was deemed unnecessary. Video ©University at Buffalo Neurosurgery, 2019. With permission.
宽颈脑动脉瘤通常需要采用复杂的治疗策略以实现最佳治疗效果。随着外科医生可用的治疗手段不断增加,考虑现有设备的所有潜在应用非常重要。编织型血管内桥接(WEB)装置(MicroVention - Terumo公司,加利福尼亚州阿利索维耶霍)利用血流阻断来促进血栓形成,并且已获得美国食品药品监督管理局(FDA)批准,用于治疗位于大脑中动脉分叉处、颈内动脉(ICA)末端、前交通动脉复合体以及基底动脉尖的囊状宽颈分叉动脉瘤。在本视频中,我们展示了WEB装置的一种非标签用途,即治疗宽颈II1型眼动脉动脉瘤,强调了正确选择装置尺寸的重要性。患者为一名74岁女性,有动脉瘤家族史。她的动脉瘤在一次轻微外伤后偶然被发现。考虑了观察和各种治疗方案。患者倾向于避免开放性手术干预和双联抗血小板治疗。II型和III型眼动脉动脉瘤的血管内血流导向治疗闭塞率相对较低,视野缺损发生率较高。1 WEB装置可以是治疗这些动脉瘤的极佳替代方案。使用双轴系统选择性地将导管插入床突上段颈内动脉,然后进入动脉瘤,实现了最佳的血流导向。患者情况良好,第二天仅服用阿司匹林后出院。六个月的血管造影显示动脉瘤接近闭塞,眼动脉通畅。颈部残余部分将在6个月后通过重复血管造影进行随访。患者已签署该手术及视频记录的知情同意书。机构审查委员会批准被认为不必要。视频©布法罗大学神经外科,2019年。经许可使用。